How to Evaluate Site SOPs During Clinical Trial Feasibility Assessments

Introduction: The Role of SOPs in Trial Readiness

Standard Operating Procedures (SOPs) are essential components of a clinical trial site’s quality system. They provide documented instructions for critical trial activities such as informed consent, investigational product (IP) handling, adverse event (AE) reporting, source data documentation, and data entry. For sponsors and CROs conducting feasibility assessments, evaluating a site’s SOP portfolio offers key insights into trial readiness, GCP compliance, and operational maturity.

During regulatory inspections, deficiencies in SOPs are frequently cited findings. These include outdated procedures, missing SOPs for core functions, or failure to follow written procedures. As a result, sponsors must thoroughly assess SOP quality, completeness, and relevance during site qualification and feasibility planning.

This article outlines a structured approach for evaluating clinical site SOPs during feasibility reviews, including checklists, document control practices, alignment with protocol needs, and inspection readiness indicators.

1. Importance of SOP Review During Feasibility

While infrastructure and staffing evaluations assess physical and human readiness, SOP review examines whether processes are standardized, traceable, and capable of consistent protocol execution. Without reliable SOPs, even experienced staff may introduce variability or overlook regulatory obligations.

Evaluating SOPs helps determine:

• If the site has written procedures for essential clinical functions
• If SOPs are up-to-date, approved, and version controlled
• If staff have been trained and documented on applicable SOPs
• If site SOPs align with sponsor expectations and protocol-specific activities

A site may have sufficient infrastructure and an experienced PI, but if there is no SOP for AE/SAE reporting or IP accountability, the trial is at risk of non-compliance.

2. Essential SOPs to Verify During Feasibility

Sponsors should request and review a list of active SOPs, particularly those relevant to clinical trial execution. The following SOPs are considered minimum requirements for most interventional studies:

Additional SOPs may be required depending on protocol complexity (e.g., genetic sample handling, radiology imaging transfer, central lab management).

3. SOP Quality Review Criteria

Beyond the presence of SOPs, sponsors should review the quality and structure of the documents. Each SOP should meet the following criteria:

• Clearly titled and numbered per a standardized SOP index
• Includes version number, effective date, and revision history
• Approved by site management and quality representatives
• Written in a clear, step-by-step format with defined roles and responsibilities
• Reflects current regulatory expectations (FDA, EMA, ICH)
• Last review date within 24 months or earlier if protocol demands updates

Example SOP Header Review:

4. Staff Training and SOP Compliance Documentation

SOPs are only useful if site staff are trained on them. Sponsors should request:

• Staff training logs indicating completion of relevant SOPs
• Sign-in sheets or electronic training records with dates
• Staff acknowledgment of role-specific SOPs
• Retraining plans for SOP revisions

Feasibility teams should verify that the PI, study coordinator, pharmacist, and lab staff have been trained on core SOPs applicable to their duties. For instance, a sub-investigator managing patient consent must be trained on the ICF process SOP.

5. SOP Alignment with Protocol and Sponsor Requirements

Some SOPs may be too generic to support protocol-specific requirements. Sponsors should identify gaps such as:

• Protocol requires SAE reporting within 24 hours, but site SOP states 72 hours
• Sponsor uses eConsent, but site SOP only covers paper-based processes
• Protocol requires weekly IP temperature uploads, but SOP outlines monthly review

In such cases, sponsors can request a protocol-specific work instruction or temporary process deviation with training logs. Sites with flexible SOP structures and rapid document revision workflows are generally better prepared for fast-paced studies.

6. SOPs and Regulatory Inspection Readiness

During FDA or EMA inspections, SOPs are routinely requested by auditors to evaluate GCP compliance. Common inspection findings include:

• No SOPs available at site during the visit
• SOPs signed by unauthorized personnel
• SOPs contradict sponsor instructions or protocol requirements
• Training logs incomplete or missing
• Staff unaware of content or location of SOPs

Sites should maintain SOPs in a central regulatory binder or electronic SOP system that is accessible to all staff. Version control, approval history, and archival practices must be documented and compliant with 21 CFR Part 11 or Annex 11 where applicable.

7. Best Practices for Sponsors and CROs

• Request SOP index and list during initial feasibility outreach
• Pre-review SOPs during pre-study visits (PSV) or remotely for e-feasibility
• Document findings using standardized SOP review templates
• Collaborate with site to align SOPs with protocol-specific needs
• Include SOP review as a line item in site qualification reports and TMF

Conclusion

Evaluating a site’s SOPs is an indispensable part of clinical trial feasibility and site qualification. SOPs are not only a reflection of operational quality but also form the basis of regulatory compliance and protocol adherence. Sponsors must move beyond check-the-box SOP lists and actively verify that procedures are documented, current, aligned with the trial, and embedded in staff training. A well-prepared site with robust SOP governance is far more likely to deliver quality data, meet timelines, and withstand regulatory scrutiny.

Developing SOPs and Templates for Clinical Trial Feasibility Assessments

Standard Operating Procedures (SOPs) and templates form the backbone of a compliant and efficient clinical trial feasibility process. They provide structure, consistency, and transparency during site qualification and selection. This guide walks you through the key elements of creating and using feasibility assessment SOPs and standardized templates that align with ICH-GCP and sponsor expectations.

Why Feasibility SOPs Are Critical

Feasibility assessments without SOPs can lead to:

• Inconsistent evaluation criteria
• Subjective site selection decisions
• Poor documentation for audits and inspections
• Overlooked risks related to staffing, infrastructure, or recruitment

Structured SOPs ensure all stakeholders follow a unified process and that documentation is suitable for regulatory inspection and TMF filing.

Core Components of a Feasibility SOP

1. Purpose and Scope

• Defines why the SOP exists (i.e., to evaluate and select suitable trial sites)
• Specifies applicable roles (sponsors, CROs, CRAs, feasibility teams)
• Outlines the lifecycle from site outreach to final selection

2. Responsibilities

• Feasibility Manager or CRA: Distribute questionnaires, schedule interviews
• Clinical Operations: Score and document responses
• Regulatory Affairs: Verify licensure, ethics committee info
• Sponsor Oversight: Final approval of site selection

3. Feasibility Workflow

1. Site pre-screening and outreach
2. Distribution of feasibility questionnaire and materials
3. Receipt, review, and clarification of responses
4. Virtual or in-person PI interview and facility tour
5. Scoring of site using predefined metrics
6. Documentation and final decision

4. Documentation Requirements

• Completed and signed feasibility questionnaire
• Investigator CVs and GCP certificates
• Site infrastructure photos or virtual tour screenshots
• Feasibility scoring sheet or site selection justification memo
• Final approval form for selected sites

Essential Feasibility Templates

Standard templates not only speed up the process but also reduce variability. Common templates include:

• Site Feasibility Questionnaire (SFQ): Tailored per protocol, covering PI experience, recruitment estimates, infrastructure, and EC timelines
• PI Interview Checklist: Covers availability, protocol understanding, and site engagement
• Infrastructure Checklist: For IP storage, diagnostics, labs, internet connectivity, and patient access
• Feasibility Scoring Matrix: Weighted scoring based on protocol-specific priorities
• Site Selection Summary Template: Documents rationale for selecting or rejecting each site

Refer to resources like Pharma SOP templates to access pre-validated forms aligned with GCP.

Integration with CTMS and eTMF Systems

Many SOPs now include digital workflows through:

• Clinical Trial Management Systems (CTMS) for site tracking
• eTMF storage of feasibility records under Section 02 (Central/Local Site Documents)
• Automated reminders for questionnaire deadlines and review cycles

Digital integration enhances traceability and audit readiness.

ICH-GCP and Regulatory Alignment

According to USFDA and CDSCO guidance, site selection must be based on documented qualification and capabilities. ICH-GCP E6(R2) requires sponsors to ensure sites have the resources to conduct the trial in compliance with the protocol and regulations. Your feasibility SOP must reflect this responsibility.

Feasibility SOP Training and Version Control

• All CRA and feasibility team members must be trained on SOP implementation
• Maintain training logs and test comprehension via post-training quizzes
• Use version control systems to track SOP revisions and effective dates

Common Pitfalls to Avoid

• Generic SOPs not tailored to therapeutic area or region
• Lack of documented site selection rationale
• Disorganized records or missing feasibility responses
• Scoring inconsistency across feasibility reviewers

Best Practices for SOP Implementation

1. Conduct feasibility kick-off meetings with all stakeholders
2. Customize templates per protocol while preserving SOP structure
3. Use feasibility decision logs for transparency
4. Review SOP compliance during site audits or monitoring visits

Conclusion

A strong SOP-driven feasibility process improves trial quality, operational efficiency, and regulatory compliance. With standardized templates and well-documented workflows, sponsors and CROs can identify, assess, and select high-performing sites with confidence. Implementing robust feasibility SOPs is not just about documentation—it’s about ensuring your clinical trial starts on a foundation of preparedness and reliability.